Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

BACKGROUND: Brimonidine tartrate is a highly selective alpha 2 agonist that induces direct vasoconstriction of small arteries and veins, thereby reducing vasodilation and edema. OBJECTIVE: To review the current literature regarding the safety, efficacy, and patient acceptability of brimonidine 0.33%...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Michael S, Nadkarni, Anish, Cardwell, Leah A, Alinia, Hossein, Feldman, Steven R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505675/
https://www.ncbi.nlm.nih.gov/pubmed/28740369
http://dx.doi.org/10.2147/PPA.S115708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505675/
https://www.ncbi.nlm.nih.gov/pubmed/28740369
http://dx.doi.org/10.2147/PPA.S115708

Ejemplares similares